...
首页> 外文期刊>Journal of Colloid and Interface Science >Folic acid decorated magnetic nanosponge: An efficient nanosystem for targeted curcumin delivery and magnetic resonance imaging
【24h】

Folic acid decorated magnetic nanosponge: An efficient nanosystem for targeted curcumin delivery and magnetic resonance imaging

机译:叶酸装饰磁性Nanosponge:靶向姜黄素递送和磁共振成像的高效纳米系统

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Magnetic drug delivery system is one of the most important strategies for cancer diagnosis and treatment. In this study, a novel theranostic system was fabricated based on cyclodextrin nanosponge (CDNS) polymer anchored on the surface of Magnetite nanoparticles (Fe3O4/CDNS NPs) which was then decorated with folic acid (FA) as a targeting agent (Fe3O4/CDNS-FA). Curcumin (CUR), a hydrophobic model drug, was next loaded into the cyclodextrin cavity and polymeric matrix of CDNS (Fe3O4/CDNSFA@CUR). The system was fully characterized. The in vitro release study revealed pH-sensitive behavior. Cytotoxicity assays indicated a negligible toxicity for CUR free Fe3O4/CDNS-FA NPs against both of M109 cancerous cells and MCF 10A normal cells. CUR-loaded Fe3O4/CDNS-FA NPs exhibited higher toxicity against M109 cancerous cells than MCF 10A normal cells (p < 0.05). Fe3O4/CDNS-FA@CUR NPs resulted in much more cell viability on normal cells than pure CUR (p < 0.05). Moreover, blood compatibility study showed minor hemolytic activity. In vitro MRI studies illustrated negative signal increase in cells affirming acceptable diagnostic ability of the nanocarrier. The T-2 MR signal intensity for Fe3O4/CDNS-FA@CUR NPs in M109 cells was around 2-fold higher than that of MCF 10A cells. This implies two times higher selective cellular uptake of the Fe3O4/CDNS-FA@CUR NPs into M109 cell compared to MCF 10A. The multifunctional nanocarrier could be considered as promising candidate for cancer theranostics because of the smart drug release, selective cytotoxicity, suitable hemocompatibility, and proper T-2 MRI contrast efficiency. (C) 2019 Elsevier Inc. All rights reserved.
机译:磁性药物递送系统是癌症诊断和治疗最重要的策略之一。在该研究中,基于锚定在磁铁矿纳米粒子(Fe3O4 / cdns NPS)表面上的环糊精纳米末期(CDN)聚合物制备了一种新的治疗系统,然后用叶酸(Fa)作为靶向剂(Fe3O4 / cdns- F A)。接下来将姜黄素(Cur),疏水模型药物加载到CDNS的环糊精腔和聚合物基质中(Fe3O4 / cdnsfa @ cur)。该系统完全表征。体外释放研究显示pH敏感行为。细胞毒性测定表明,对M109癌细胞和MCF 10A正常细胞的RIC FE3O4 / CDNS-FA NP的毒性可忽略不计。 Cur-Loaded Fe3O4 / CDNS-FA NPS对M109癌细胞的毒性高于MCF 10A正常细胞(P <0.05)。 FE3O4 / CDNS-FA @ Cur NPS在正常细胞上产生的细胞活力远比纯Cur(P <0.05)。此外,血液相容性研究显示少量溶血活性。体外MRI研究说明了细胞中的负信号增加,肯定了纳米载体的可接受的诊断能力。 M109细胞中Fe3O4 / CDNS-FA @ Cur NPS的T-2 MR信号强度比MCF 10A细胞高约2倍。与MCF 10a相比,这意味着FE3O4 / CDNS-CDNS-FA @ Cure9细胞的FE3O4 / CDNS-FA @ Cur NP的选择性蜂窝摄取较高的两倍。由于智能药物释放,选择性细胞毒性,适当的血液相位性,适当的T-2 MRI对比度,可以将多功能纳米载体视为癌症治疗患者的候选者。 (c)2019 Elsevier Inc.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号